专利检索 ap:("UNION therapeutics A/S") AND inv:"Mark Andrews" 第 1 页

1.

发明授权
Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors 有权

公开(公告)号：US11292799B2

公开(公告)日：2022-04-05

申请号：US16772428

申请日：2018-12-14

申请人： UNION therapeutics A/S

发明人： Mark Andrews , Daniel Rodriguez Greve , Jens Larsen

IPC分类号： C07D495/04

摘要： The present invention relates to novel substituted azetidine dihydrothienopyrimidines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I).

2.

发明授权
Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors 有权

公开(公告)号：US11981681B2

公开(公告)日：2024-05-14

申请号：US17805875

申请日：2022-06-08

申请人： UNION therapeutics A/S

发明人： Mark Andrews , Daniel Rodriguez Greve , Bjarne Nørremark

IPC分类号： C07D495/04 , A61K31/4365 , A61P17/00 , A61K31/4545

CPC分类号： C07D495/04 , A61P17/00 , A61K31/4365 , A61K31/4545

摘要： The present invention relates to novel substituted azetidine dihydrothienopyridines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I)

3.

发明授权
Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors 有权

公开(公告)号：US11384096B2

公开(公告)日：2022-07-12

申请号：US16772615

申请日：2018-12-14

申请人： UNION therapeutics A/S

发明人： Mark Andrews , Daniel Rodriguez Greve , Bjarne Nørremark

IPC分类号： C07D495/04 , A61P17/00 , A61K31/4365 , A61K31/4545

摘要： The present invention relates to novel substituted azetidine dihydrothienopyridines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I)